Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOSE MD AVILA ORNELAS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1467868927
CMS profile
4900804
Location
CAGUAS, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$109,055.80

188 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOSE MD AVILA ORNELAS

NPI 1467868927 · CMS profile ID 4900804

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

CAGUAS, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1467868927?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOSE MD AVILA ORNELAS, NPI 1467868927, CMS profile ID 4900804. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1467868927?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JOSE MD AVILA ORNELAS, NPI 1467868927, CMS profile ID 4900804. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1467868927?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JOSE MD AVILA ORNELAS, NPI 1467868927, CMS profile ID 4900804, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1467868927?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

188 matching records · $109,055.80 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 188 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 188.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $79.1805/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991623969 CMS
Biogen, Inc. $53.3305/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012193655 CMS
Biogen, Inc. $3,678.0005/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012206409 CMS
Biogen, Inc. $41.6705/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012210883 CMS
E.R. Squibb & Sons, L.L.C. $19.6205/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015339763 CMS
Novartis Pharmaceuticals Corporation $6.4205/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991624013 CMS
Novartis Pharmaceuticals Corporation $3.6305/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991624017 CMS
TG Therapeutics, Inc. $115.3405/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051474219 CMS
Biogen, Inc. $15.9905/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012203275 CMS
E.R. Squibb & Sons, L.L.C. $17.5805/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015339811 CMS
Novartis Pharmaceuticals Corporation $17.8405/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991623973 CMS
ANI Pharmaceuticals, Inc. $22.3805/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034169171 CMS
Biogen, Inc. $11.8305/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012153265 CMS
BANNER LIFE SCIENCES, LLC $22.3705/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021110659 CMS
BANNER LIFE SCIENCES, LLC $1.1405/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021110661 CMS
BANNER LIFE SCIENCES, LLC $8.5505/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021110605 CMS
E.R. Squibb & Sons, L.L.C. $19.1405/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015339721 CMS
Biogen, Inc. $27.0704/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012281379 CMS
EMD Serono, Inc. $124.5304/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032569213 CMS
EMD Serono, Inc. $86.5104/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032571741 CMS
Genentech USA, Inc. $23.9504/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040412229 CMS
EMD Serono, Inc. $18.9504/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032499929 CMS
Biogen, Inc. $3.9204/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012150221 CMS
Genentech, Inc. $92.4204/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040412261 CMS
Biogen, Inc. $22.6004/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012136383 CMS
E.R. Squibb & Sons, L.L.C. $18.9504/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015339714 CMS
Biogen, Inc. $153.0004/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012268723 CMS
Novartis Pharmaceuticals Corporation $6.7604/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991624009 CMS
BANNER LIFE SCIENCES, LLC $25.3004/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021109731 CMS
Biogen, Inc. $14.3003/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012200205 CMS
Novartis Pharmaceuticals Corporation $7.0803/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991624005 CMS
EMD Serono, Inc. $193.6103/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032569399 CMS
EMD Serono, Inc. $32.7703/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032571657 CMS
EMD Serono, Inc. $65.5403/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032589807 CMS
EMD Serono, Inc. $34.6203/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032590485 CMS
Genentech USA, Inc. $17.1203/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040412255 CMS
Novartis Pharmaceuticals Corporation $5.8503/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991624001 CMS
Alexion Pharmaceuticals, Inc. $1,770.0003/21/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017070443 CMS
BANNER LIFE SCIENCES, LLC $28.4403/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021109467 CMS
Horizon Therapeutics plc $2,700.0003/17/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986945395 CMS
Horizon Therapeutics plc $746.4003/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986945399 CMS
Horizon Therapeutics plc $644.3803/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986945401 CMS
Horizon Therapeutics plc $119.8703/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986945405 CMS
Horizon Therapeutics plc $2,160.0003/17/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986945409 CMS
Horizon Therapeutics plc $119.8903/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986945413 CMS
Horizon Therapeutics plc $127.3603/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986945417 CMS
Novartis Pharmaceuticals Corporation $56.0703/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991623953 CMS
Novartis Pharmaceuticals Corporation $43.8203/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991623957 CMS
Horizon Therapeutics plc $42.2403/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986945383 CMS
Horizon Therapeutics plc $4,500.0003/16/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986945387 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $55,471.48 124
PY2020 $44,246.85 77
PY2021 $45,154.46 142
PY2022 $77,162.19 186
PY2023 $109,055.80 188
PY2024 $118,070.59 211
PY2025 $88,576.15 184

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,996.00 1
PY2025 Principal investigator $319,360.27 5
PY2024 Recipient $3,640.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $249.21 10/28/2025 Non-covered Recipient Entity
PUERTO RICO MULTIPLE SCLEROSIS CENTER
A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, Followed by Open-label Treatment With R No dispute reported 06/30/2026 1190312787
Principal investigator 1 Novartis Pharmaceuticals Corporation $255,938.33 10/27/2025 Non-covered Recipient Entity
PUERTO RICO MULTIPLE SCLEROSIS CENTER
A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament Light No dispute reported 06/30/2026 1190312789
Principal investigator 1 Celgene Corporation $20,662.50 10/02/2025 Non-covered Recipient Entity
Puerto Rico Multiple Sclerosis Center
A Phase 2, Randomized, Double-blind, Four-arm, Placebo-controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of three doses of orally administered BMS-986368, a FAAH/MAGL Inhibitor, vs. placebo for the Treatment of Spasticity in Participants with Multiple Sclerosis. No dispute reported 06/30/2026 1222306927
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $4,419.04 05/27/2025 Non-covered Recipient Entity
Puerto Rico Multiple Sclerosis Center
A Phase 2, Randomized, Double-blind, Four-arm, Placebo-controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of three doses of orally administered BMS-986368, a FAAH/MAGL Inhibitor, vs. placebo for the Treatment of Spasticity in Participants with Multiple Sclerosis. No dispute reported 06/30/2026 1235994427
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $38,091.19 04/30/2025 Non-covered Recipient Entity
Puerto Rico Multiple Sclerosis Center
A Phase 2, Randomized, Double-blind, Four-arm, Placebo-controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of three doses of orally administered BMS-986368, a FAAH/MAGL Inhibitor, vs. placebo for the Treatment of Spasticity in Participants with Multiple Sclerosis. No dispute reported 06/30/2026 1235994429
Recipient Alexion Pharmaceuticals, Inc. $1,996.00 02/25/2025 Covered Recipient Physician A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT) No dispute reported 06/30/2026 1185539165